Drug profile · INN
sebelipase alfa
KANUMA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
sebelipase alfa (KANUMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN sebelipase alfa
Brand KANUMA
Route INJECTION
Formulation INJECTABLE
ATC code A16
Frequently asked questions
What is sebelipase alfa?
sebelipase alfa (KANUMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sebelipase alfa?
KANUMA is a marketed brand name for sebelipase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sebelipase alfa?
sebelipase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.